Home » Topics » Regulatory

Regulatory
RSS

European Commission approves pegfilgrastim biosimilar Udenyca

Sep. 26, 2018

FDA grants approval for Copiktra for CLL/SLL, accelerated approval in follicular lymphoma

Sep. 25, 2018

Xospata approved in Japan for FLT3 mutation-positive relapsed or refractory AML

Sep. 25, 2018

Beova granted marketing approval in Japan for overactive bladder

Sep. 25, 2018

Eybelis granted marketing approval for glaucoma and ocular hypertension in Japan

Sep. 25, 2018

Lorlatinib receives first approval in Japan

Sep. 21, 2018

Hulio, a biosimilar to adalimumab, receives marketing authorization in Europe

Sep. 21, 2018

FDA approves Ajovy for preventive treatment of migraine

Sep. 17, 2018

FDA approves Lumoxiti for relapsed or refractory hairy cell leukemia

Sep. 14, 2018

Ozalin becomes the first oral pediatric sedative to receive marketing authorization in Europe

Sep. 14, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 10, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld
Hematopoietic stem cell research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
Korsana boosts Alzheimer’s work with reverse merger, $380M financing
BioWorld Science
Just over a month after emerging from stealth and disclosing a $150 million series A, Korsana Biosciences Inc. is making the leap to the public market via a...